European Commission
English

Kohesio: discover EU projects in your region

   
more info
Start date: 23 February 2017
End date: 19 May 2022
Number of projects: 14
Total budget: 14 693 402,79 €
EU contribution: 9 904 507,56 €
Website: n/a
Country: European Commission Flag
Explore more: n/a
funds
ERDF: 9 904 507,56 €

1 - 14 of 14
PROJECTTOTAL BUDGETEU CONTRIBUTIONFUNDGENOMICS AND THERAPY 8 146 000,00 € 6 109 500,00 € ERDF INTEGRATED TECHNOLOGICAL PLATFORM FOR THE IDENTIFICATION AND DEVELOPMENT OF NEW DRUGS FOR THE TREATMENT OF RARE DISEASES OR HIGH NEED FOR UNMET CARE 1 357 576,50 € 984 689,69 € ERDF GENE-ELECTRO-TRANSFER OF NEOEPITOPES — GET-NEO 582 695,00 € 422 645,62 € ERDF REVER3BAB: AN INNOVATIVE BIOLOGICAL MEDICINE FOR REVERTIRE THE RESISTANCE TO CONVENTIONAL CANCER TREATMENT 829 236,60 € 409 635,99 € ERDF GENERATION OF NEW CAR T AND BITES TO CONVERT THE TUMOR MICROENVIRONMENT 740 690,56 € 370 345,28 € ERDF DEVELOPMENT OF AN IMMUNOTHERAPY PLATFORM FOR THE TREATMENT OF SARCOMA PATIENTS 609 205,44 € 304 444,81 € ERDF DEVELOPMENT OF METHODS OF PRODUCTION AND PURIFICATION OF EXPRESSION VECTORS FOR CLINICAL USE (AAV, HSV-1, MVA, DNA) — VECTOPUR 406 259,34 € 294 671,72 € ERDF DEVELOPMENT OF A HUMANISED MOUSE MODEL FOR THE GENERATION OF MONOCLONAL ANTIBODIES. 469 035,91 € 233 753,62 € ERDF INTEGRATION OF HIGH-THROUGHPUT TECHNOLOGIES FOR FAST ANTIBODY SCREENING FOR ANTITUMO THERAPIES 416 810,62 € 208 405,31 € ERDF PRODUCTION AND SCALE-UP IN BIORETTORE OF RETROVIRAL VECTORS 387 416,50 € 193 708,23 € ERDF GENES 348 047,22 € 174 019,44 € ERDF FOR MENHUB: CREATION OF AN INDUSTRIAL MAGNET FOR BIOTECH COMPANIES IN LAZIO BASED ON TE 335 723,24 € 152 835,47 € ERDF DEVELOPMENT OF A MONOCLONAL ANTIBODY AS A THERAPEUTIC TREATMENT IN THE AREA OF INFECTIOUS DISEASES (DAMCLUAB) 53 997,82 € 40 498,36 € ERDF DEVELOPMENT OF A HIGH-THROUGHPUT PROCESS FOR THE PRODUCTION OF DIAGNOSTIC MONOCLONAL ANTIBODIES 10 708,04 € 5 354,02 € ERDF